Lantheus Announces Presentation Featuring PYLARIFY® (Pi

American Society for Clinical Oncology Genitourinary (ASCO GU) Meeting, Piflufolastat F 18-PET/CT in Prostate Cancer, Analysis of OSPREY, artificial intelligence solutions for prostate cancer.

Related Keywords

Maryland , United States , San Francisco , California , American , Michael Gorin , Lantheus Holdings Inc , Urology Associates , Lantheus Holdings , Clinical Oncology Genitourinary , Poster Session , Prostate Cancer , Standardized Uptake Value , Results Stratified , Gleason Score ,